Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-13 Sale | 2023-09-14 4:14 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 12,401 | $1.3257 | $16,440 | 596,241 (Direct) | View |
| 2023-09-13 Sale | 2023-09-14 4:14 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 6,411 | $1.3257 | $8,499 | 249,559 (Direct) | View |
| 2023-09-13 Sale | 2023-09-14 4:13 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 8,998 | $1.3257 | $11,929 | 378,087 (Direct) | View |
| 2023-09-13 Sale | 2023-09-14 4:13 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks | 2,505 | $1.3257 | $3,321 | 85,520 (Direct) | View |
| 2023-09-13 Sale | 2023-09-14 4:13 pm | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 17,830 | $1.3257 | $23,637 | 976,614 (Indirect Direct) | View |
| 2023-06-14 Sale | 2023-06-15 4:30 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director | 115 | $0.3481 | $40 | 147,514 (Direct) | View |
| 2023-06-14 Sale | 2023-06-15 4:30 pm | Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director | 115 | $0.3481 | $40 | 147,514 (Direct) | View |
| 2023-06-14 Sale | 2023-06-15 4:29 pm | Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director | 115 | $0.3481 | $40 | 147,514 (Direct) | View |
| 2023-06-14 Sale | 2023-06-15 4:29 pm | Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director | 115 | $0.3481 | $40 | 147,514 (Direct) | View |
| 2023-06-14 Sale | 2023-06-15 4:28 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 115 | $0.3481 | $40 | 152,501 (Direct) | View |
| 2023-06-14 Sale | 2023-06-15 4:28 pm | Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director | 115 | $0.3481 | $40 | 147,514 (Direct) | View |
| 2023-02-15 Sale | 2023-02-17 4:21 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 3,173 | $0.5418 | $1,719 | 227,018 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:29 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 24,661 | $0.5978 | $14,742 | 513,204 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:28 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 17,769 | $0.5978 | $10,622 | 324,736 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:26 pm | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 12,663 | $0.5978 | $7,570 | 214,848 (Direct) | View |
| 2023-01-23 Sale | 2023-01-25 5:25 pm | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 35,453 | $0.5978 | $21,194 | 866,127 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-10 Equity Swap | 2023-10-11 10:17 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks | 115,520 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 10:17 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks | 30,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:12 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director | 75,778 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:12 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 548,087 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 10:12 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 170,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:08 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 766,241 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 10:08 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 170,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:07 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director | 75,778 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:05 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 369,559 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 10:05 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 120,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:03 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director | 75,778 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 10:02 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 312,018 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 10:02 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 85,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 09:58 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 80,765 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 09:58 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director | 75,778 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 09:52 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 1,216,614 | $0 | 0 (Direct) | View |
| 2023-10-10 Option Award | 2023-10-11 09:52 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 240,000 | $0 | 0 (Direct) | View |
| 2023-10-10 Equity Swap | 2023-10-11 09:52 am | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director | 75,778 | $0 | 0 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 4:14 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 45,000 | $0 | 596,241 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 4:14 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 22,200 | $0 | 249,559 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 4:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 31,200 | $0 | 378,087 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 4:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks | 9,000 | $0 | 85,520 (Direct) | View |
| 2023-09-12 Option Award | 2023-09-14 4:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 64,747 | $0 | 976,614 (Direct) | View |
Ownership | 2023-08-15 4:05 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Jones Kenneth T See Remarks | 0 | $0 | 221,775 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:30 pm | N/A 2033-06-13 | Zynerba Pharmaceuticals Inc. | ZYNE | Stephenson Pamela Director | 119,560 | $0 | 147,514 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:30 pm | N/A 2033-06-13 | Zynerba Pharmaceuticals Inc. | ZYNE | MOCH KENNETH I Director | 119,560 | $0 | 147,514 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:29 pm | N/A 2033-06-13 | Zynerba Pharmaceuticals Inc. | ZYNE | KISNER DANIEL L Director | 119,560 | $0 | 147,514 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:29 pm | N/A 2033-06-13 | Zynerba Pharmaceuticals Inc. | ZYNE | FEDERICI WILLIAM J Director | 119,560 | $0 | 147,514 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:28 pm | N/A 2033-06-13 | Zynerba Pharmaceuticals Inc. | ZYNE | Butler John P. Director | 119,560 | $0 | 152,501 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 4:28 pm | N/A 2033-06-13 | Zynerba Pharmaceuticals Inc. | ZYNE | COOPER WARREN D Director | 119,560 | $0 | 147,514 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:20 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 5,145 | $0.5965 | 233,770 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:20 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 14,926 | $0 | 233,770 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:11 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 6,544 | $0.5965 | 355,885 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:11 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 22,547 | $0 | 355,885 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:11 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 9,973 | $0.5965 | 563,642 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:11 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 36,044 | $0 | 563,642 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 12,547 | $0.5965 | 929,697 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 45,406 | $0 | 929,697 (Direct) | View |
| 2023-02-08 Tax Withholding | 2023-02-09 5:09 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 5,463 | $0.5965 | 230,191 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 5:09 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 18,864 | $0 | 230,191 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 11,726 | $0.5952 | 896,838 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:13 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 42,437 | $0 | 896,838 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:12 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 5,841 | $0.5952 | 216,790 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:12 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 17,631 | $0 | 216,790 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 4,809 | $0.5952 | 223,989 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:10 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 13,950 | $0 | 223,989 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:08 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 5,927 | $0.5952 | 339,882 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:08 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 21,073 | $0 | 339,882 (Direct) | View |
| 2023-02-01 Tax Withholding | 2023-02-02 8:06 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 9,321 | $0.5952 | 537,571 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 8:06 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 33,688 | $0 | 537,571 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:30 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Parker Albert P Chief Legal Officer | 170,000 | $0 | 205,000 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:29 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Sebree Terri B President | 170,000 | $0 | 513,204 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:28 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Fickenscher James E Chief Financial Officer | 170,000 | $0 | 324,736 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:26 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | Rosenberger Brian VP, Commercial & Business Dev. | 120,000 | $0 | 214,848 (Direct) | View |
| 2023-01-24 Option Award | 2023-01-25 5:25 pm | N/A N/A | Zynerba Pharmaceuticals Inc. | ZYNE | ANIDO ARMANDO Chairman & Chief Exec. Officer | 250,000 | $0 | 866,127 (Direct) | View |